155 related articles for article (PubMed ID: 30298320)
1. Influence of Age on the Clinical Outcome of Breast Cancer for Men and the Development of Second Primary Cancers.
Cronin PA; Romanoff A; Zabor EC; Stempel M; Eaton A; Smyth LM; Ho AY; Morrow M; El-Tamer M; Gemignani ML
Ann Surg Oncol; 2018 Dec; 25(13):3858-3866. PubMed ID: 30298320
[TBL] [Abstract][Full Text] [Related]
2. Outcome of male breast cancer: a matched single-institution series.
Iorfida M; Bagnardi V; Rotmensz N; Munzone E; Bonanni B; Viale G; Pruneri G; Mazza M; Cardillo A; Veronesi P; Luini A; Galimberti V; Goldhirsch A; Colleoni M
Clin Breast Cancer; 2014 Oct; 14(5):371-7. PubMed ID: 24742826
[TBL] [Abstract][Full Text] [Related]
3. Molecular Characterization and Mortality From Breast Cancer in Men.
Massarweh SA; Sledge GW; Miller DP; McCullough D; Petkov VI; Shak S
J Clin Oncol; 2018 May; 36(14):1396-1404. PubMed ID: 29584547
[TBL] [Abstract][Full Text] [Related]
4. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.
Jeon YW; Kang SH; Park MH; Lim W; Cho SH; Suh YJ
BMC Cancer; 2015 Nov; 15():865. PubMed ID: 26546331
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
Amirifard N; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
[TBL] [Abstract][Full Text] [Related]
7. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
Chen W; Huang Y; Lewis GD; Szeja SS; Hatch SS; Farach A; Miltenburg D; Butler EB; Chang JC; Teh BS
Clin Breast Cancer; 2018 Feb; 18(1):e97-e105. PubMed ID: 28888581
[TBL] [Abstract][Full Text] [Related]
8. Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.
Leone J; Zwenger AO; Leone BA; Vallejo CT; Leone JP
Am J Clin Oncol; 2019 Feb; 42(2):215-220. PubMed ID: 30499840
[TBL] [Abstract][Full Text] [Related]
9. Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy.
Mougalian SS; Hernandez M; Lei X; Lynch S; Kuerer HM; Symmans WF; Theriault RL; Fornage BD; Hsu L; Buchholz TA; Sahin AA; Hunt KK; Yang WT; Hortobagyi GN; Valero V
JAMA Oncol; 2016 Apr; 2(4):508-16. PubMed ID: 26720612
[TBL] [Abstract][Full Text] [Related]
10. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and biological characteristics of male breast cancer in Italy.
Mangone L; Ferrari F; Mancuso P; Carrozzi G; Michiara M; Falcini F; Piffer S; Filiberti RA; Caldarella A; Vitale F; Tumino R; Brustolin A; Tagliabue G; Giorgi Rossi P; Ottini L
Breast Cancer; 2020 Jul; 27(4):724-731. PubMed ID: 32114665
[TBL] [Abstract][Full Text] [Related]
12. Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma.
Farr DE; Thomas A; Khan SA; Schroeder MC
Oncologist; 2017 Aug; 22(8):895-900. PubMed ID: 28487463
[TBL] [Abstract][Full Text] [Related]
13. Male breast cancers behave differently in elderly patients.
Tural D; Selçukbiricik F; Aydoğan F; Beşe N; Yetmen O; Ilvan Ş; Büyükünal E; Serdengeçti S
Jpn J Clin Oncol; 2013 Jan; 43(1):22-7. PubMed ID: 23159765
[TBL] [Abstract][Full Text] [Related]
14. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer.
Cadoo KA; Morris PG; Cowell EP; Patil S; Hudis CA; McArthur HL
Clin Breast Cancer; 2016 Dec; 16(6):487-493. PubMed ID: 27622751
[TBL] [Abstract][Full Text] [Related]
17. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer.
Chattopadhyay S; Hemminki O; Försti A; Sundquist K; Sundquist J; Hemminki K
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):143-149. PubMed ID: 30185889
[TBL] [Abstract][Full Text] [Related]
18. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
19. Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer.
Fogh S; Hirsch AE; Langmead JP; Goldberg SI; Rosenberg CL; Taghian AG; Powell SN; Kachnic LA
Clin Breast Cancer; 2011 Mar; 11(1):39-45. PubMed ID: 21421521
[TBL] [Abstract][Full Text] [Related]
20. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
